Literature DB >> 24856775

European Cystic Fibrosis Society Standards of Care: Best Practice guidelines.

Alan R Smyth1, Scott C Bell2, Snezana Bojcin3, Mandy Bryon4, Alistair Duff5, Patrick Flume6, Nataliya Kashirskaya7, Anne Munck8, Felix Ratjen9, Sarah Jane Schwarzenberg10, Isabelle Sermet-Gaudelus11, Kevin W Southern12, Giovanni Taccetti13, Gerald Ullrich14, Sue Wolfe15.   

Abstract

Specialised CF care has led to a dramatic improvement in survival in CF: in the last four decades, well above what was seen in the general population over the same period. With the implementation of newborn screening in many European countries, centres are increasingly caring for a cohort of patients who have minimal lung disease at diagnosis and therefore have the potential to enjoy an excellent quality of life and an even greater life expectancy than was seen previously. To allow high quality care to be delivered throughout Europe, a landmark document was published in 2005 that sets standards of care. Our current document builds on this work, setting standards for best practice in key aspects of CF care. The objective of our document is to give a broad overview of the standards expected for screening, diagnosis, pre-emptive treatment of lung disease, nutrition, complications, transplant/end of life care and psychological support. For comprehensive details of clinical care of CF, references to the most up to date European Consensus Statements, Guidelines or Position Papers are provided in Table 1. We hope that this best practice document will be useful to clinical teams both in countries where CF care is developing and those with established CF centres.
Copyright © 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Multidisciplinary management; Standards of care

Mesh:

Year:  2014        PMID: 24856775     DOI: 10.1016/j.jcf.2014.03.010

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  98 in total

Review 1.  Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2016-08       Impact factor: 9.546

2.  Volumetric dynamic oxygen-enhanced MRI (OE-MRI): comparison with CT Brody score and lung function in cystic fibrosis patients.

Authors:  K Martini; C M Gygax; C Benden; A R Morgan; G J M Parker; T Frauenfelder
Journal:  Eur Radiol       Date:  2018-04-13       Impact factor: 5.315

Review 3.  The Effect of Ancestry and Genetic Variation on Lung Function Predictions: What Is "Normal" Lung Function in Diverse Human Populations?

Authors:  Victor E Ortega; Rajesh Kumar
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

4.  Positive Newborn Screening for Cystic Fibrosis, What to Do Next?

Authors:  Prawin Kumar; Jagdish Prasad Goyal
Journal:  Indian J Pediatr       Date:  2019-07-19       Impact factor: 1.967

5.  Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012.

Authors:  Abaigeal D Jackson; Andrew L Jackson; Godfrey Fletcher; Gerardine Doyle; Mary Harrington; Shijun Zhou; Fiona Cullinane; Charles Gallagher; Edward McKone
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

Review 6.  Multidisciplinary Care for Cystic Fibrosis Liver Disease: Where Does the Adult Hepatologist Fit In?

Authors:  Fares Ayoub; Hechu Li; Charles Blay; Cesar Trillo-Alvarez; Jorge Lascano; Giuseppe Morelli
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-12-20

Review 7.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

8.  Treating Cough Due to Non-CF and CF Bronchiectasis With Nonpharmacological Airway Clearance: CHEST Expert Panel Report.

Authors:  Adam T Hill; Alan F Barker; Donald C Bolser; Paul Davenport; Belinda Ireland; Anne B Chang; Stuart B Mazzone; Lorcan McGarvey
Journal:  Chest       Date:  2018-01-31       Impact factor: 9.410

Review 9.  Cystic Fibrosis.

Authors:  Susanne Naehrig; Cho-Ming Chao; Lutz Naehrlich
Journal:  Dtsch Arztebl Int       Date:  2017-08-21       Impact factor: 5.594

Review 10.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.